Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Vaccines and Influenza Drugs Market to Grow 10.24% CAGR by 2022 Says a new Research at ReportsnReports
  • USA - English


News provided by

ReportsnReports

20 Jul, 2017, 22:30 IST

Share this article

Share toX

Share this article

Share toX

PUNE, India, July 20, 2017 /PRNewswire/ --

Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) report has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.

Browse 78 Tables and Figures, 10 Companies Profiles, spread across 164 pages @ http://www.reportsnreports.com/reports/1010794-global-influenza-drugs-and-vaccines-market-by-drugs-zanamivir-oseltamivir-phosphate-peramivir-by-vaccine-trivalent-quadrivalent-analysis-by-region-by-country-opportunities-and-forecast-2016-2021-ia-japan.html.

Global Influenza Drugs and Vaccines Market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 - 2022, chiefly driven by increasing spending over various immunization programmes. Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.

Company Profile Analysis covered in this Report - Falvogen, Gilead Science and Bio Cryst, GlaxoSmithKline, Sanofi Pasteur, Inc., CSL Limited, Astrazeneca, Protein Sciences Corporation, Serum Institute of India Pvt. Ltd., Emergent Biosolutions, Emergent Biosolutions, BioCryst Pharmaceuticals.Inc., and Alvogen. Order a copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=1010794.

Scope of the Report: Global Influenza Market; Regional Markets - North America, Europe, APAC, RoW; Country Analysis - US, Canada, UK, Germany, France, Japan, China, India; 

(Actual Period: 2012-2016E, Forecast Period: 2017-2022)
By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
By Vaccine Type: Trivalent, Quadrivalent
By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir

Table of Contents 

Influenza Market: An Introduction
Global Influenza Market Overview
Global Influenza Market: Product Analysis
Global Influenza Vaccines & Drugs - Pipeline Analysis
Global Influenza Market, Breakdown By Region 

Other related report Global Lysine Market by Manufacturers, Countries, Type and Application, Forecast to 2022 is a professional and in-depth study on the current state of the Lysine industry. The Lysine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions development status. Report provides Introduction, product scope, market overview, market opportunities, market risk, and market driving force. This report focuses on the Lysine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. This report covers market segment by manufacturers: CJ(KR), Ajinomoto(JP), ADM(US), Evonik(DE), GLOBAL Bio-Chem(CN), Meihua(CN), COFCO(CN), East Hope(CN), Juneng Golden Corn(CN), and Chengfu Group(CN).

About Us: 

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001
Maharashtra, India.
+1-8883915441
[email protected]

Connect With Us On: 

RSS Link: http://www.reportsnreports.com/feed/p-210-azoth-analytics.xml

LinkedIn: http://www.linkedin.com/company/reportsnreports

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.